Walleye Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$749K Buy
10,600
+2,900
+38% +$157K ﹤0.01% 2374
2026
Q1
$402K Sell
7,700
-1,500
-16% -$90K ﹤0.01% 2827
2025
Q4
$541K Sell
9,200
-4,900
-35% -$298K ﹤0.01% 2916
2025
Q3
$784K Buy
14,100
+2,700
+24% +$145K ﹤0.01% 2284
2025
Q2
$587K Buy
+11,400
New +$573K ﹤0.01% 2502
2024
Q4
Sell
-100
Closed -$7.99K 5545
2024
Q3
$7.99K Sell
100
-1,800
-95% -$135K ﹤0.01% 4945
2024
Q2
$136K Sell
1,900
-200
-10% -$14.7K ﹤0.01% 4550
2024
Q1
$148K Sell
2,100
-200
-9% -$14.3K ﹤0.01% 4164
2023
Q4
$177K Buy
+2,300
New +$151K ﹤0.01% 3746
2023
Q3
Sell
-1,100
Closed -$89.8K 5320
2023
Q2
$89.8K Sell
1,100
-400
-27% -$32.2K ﹤0.01% 3469
2023
Q1
$111K Buy
+1,500
New +$116K ﹤0.01% 2869

Other funds holding TECH

Walleye Capital's TECH Position: Q2 2026 in Review

Walleye Capital reduced its Bio-Techne (TECH) stake by 98% in Q2 2026, selling an estimated $7.02M and leaving 2,401 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #3597.

Walleye Capital first reported a position in TECH in Q1 2022 and has held it in 11 quarters since. The position peaked at $24.7M in Q3 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Walleye Capital held 2,401 shares of Bio-Techne worth $170K as of Q2 2026.
  • Walleye Capital sold 130,006 Bio-Techne shares in Q2 2026, an estimated $7.02M.
  • Bio-Techne made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3597 holding.
  • Walleye Capital first reported a position in Bio-Techne in Q1 2022 and has held it in 11 quarters since.
  • Walleye Capital's Bio-Techne position peaked at $24.7M in Q3 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.